Your search returned 97 studies. (Get alerts for new studies):
- ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Conditions: Coronary Artery Disease
Location: Little Rock, Alaska
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Little Rock, Arizona
- Combining Lesinurad With Allopurinol in Inadequate Responders
Conditions: Gout
Location: Little Rock, Arizona
- Combining Lesinurad With Allopurinol in Inadequate Responders
Conditions: Gout
Location: Little Rock, Arizona
- FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study
Conditions: Kidney Failure, Chronic - End Stage Renal Disease, Requiring Dialysis
Location: Hot Springs, Arkansas
- The PACE-MI Registry Study
Conditions: Myocardial Infarction
Location: Little Rock, Arkansas
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Hot Springs, Arkansas
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Little Rock, Arkansas
- Evaluating the Effectiveness of the LifeVest Defibrillator and Improving Methods for Determining the Use of Implantable Cardioverter Defibrillators
Conditions: Death, Sudden, Cardiac - Myocardial Infarction - Arrhythmias, Cardiac
Location: Little Rock, Arkansas
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Little Rock, Arkansas
- Study of New Implantable Loop Recorder
Conditions: Tachyarrhythmias - Syncope
Location: Little Rock, Arkansas
- A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
Conditions: Non Small Cell Lung Cancer
Location: Hot Springs, Arkansas
- Safety and Efficacy of Cariprazine for Bipolar I Disorder
Conditions: Mania - Bipolar I Disorder
Location: Little Rock, Arkansas
- Efficacy and Safety of Abatacept Subcutaneous (SC) in Combination With Methotrexate in Adults With Very Early Rheumatoid Arthritis (RA)
Conditions: Rheumatoid Arthritis
Location: Hot Springs, Arkansas
- Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.
Conditions: Plaque Psoriasis
Location: Hot Springs, Arkansas
- Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail
Conditions: Onychomycosis of Toenails
Location: Hot Springs, Arkansas
- Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
Conditions: Rosacea
Location: Hot Springs, Arkansas
- An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Conditions: Chemotherapy-Induced Nausea and Vomiting
Location: Hot Spring, Arkansas
- Growth and Tolerance of Hypoallergenic Formulas
Conditions: Growth of Term Infants
Location: Benton, Arkansas
- A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving
Conditions: Rheumatoid Arthritis
Location: Hot Springs, Arkansas
- Permissive Hypercapnia and Brain Development in Premature Infants
Conditions: Premature Birth
Location: Little Rock, Arkansas
- An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Conditions: Chemotherapy-Induced Nausea and Vomiting
Location: Hot Springs, Arkansas
- Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurre
Conditions: Non-Small Cell Lung Cancer
Location: Hot Springs, Arkansas
- Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Conditions: Angina Pectoris - Coronary Artery Disease - Type 2 Diabetes Mellitus
Location: Little Rock, Arkansas
- Sleep Disordered Breathing and Chronic Pain
Conditions: Sleep Apnea Syndromes
Location: Little Rock, Arkansas
- A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes
Conditions: Type 2 Diabetes Mellitus
Location: Little Rock, Arkansas
- Improving Outcomes for Hypertensive Children
Conditions: Hypertension
Location: Little Rock, Arkansas
- Riata® Lead Evaluation Post Market Study
Conditions: Incidence of Externalized Cables in Riata Leads
Location: Little Rock, Arkansas
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Little Rock, Arkansas
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Little Rock, Arkansas
- A MRI Study of Visual and Motor Pathways in Premature Infants
Conditions: Premature Birth
Location: Little Rock, Arkansas
- A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Conditions: Painful Diabetic Neuropathy
Location: Hot Springs, Arkansas
- Quadripolar Pacing Post Approval Study
Conditions: Heart Failure
Location: Little Rock, Arkansas
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Hot Springs, Arkansas
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Hot Springs, Arkansas
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Hot Springs, Arkansas
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Little Rock, Arkansas
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Hot Springs, Arkansas
- A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
Conditions: Optic Neuropathy, Ischemic
Location: Little Rock, Arkansas
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Hot Springs, Arkansas
- Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
Conditions: Bipolar - Depression
Location: Little Rock, Arkansas
- Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Conditions: Benign Prostatic Hyperplasia
Location: Little Rock, Arkansas
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: Hot Springs, Arkansas
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Little Rock, Arkansas
- Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome
Location: Hot Springs, Arkansas
- Continued Safety Monitoring of Solanezumab in Alzheimer's Disease
Conditions: Alzheimer's Disease
Location: Little Rock, Arkansas
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Hot Springs, Arkansas
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Little Rock, Arkansas
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Little Rock, Arkansas
- Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
Conditions: Thrombocytopaenia
Location: Hot Springs, Arkansas
- A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Conditions: Psoriasis
Location: Hot Springs, Arkansas
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Little Rock, Arkansas
- A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate
Conditions: Rheumatoid Arthritis
Location: Hot Springs, Arkansas
- A Rheumatoid Arthritis Study in Patients
Conditions: Rheumatoid Arthritis
Location: Hot Springs, Arkansas
- A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus - Connective Tissue Disease - Autoimmune Disease
Location: Malvern, Arkansas
- An Open Label Study for Patients With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Location: Hot Springs, Arkansas
- Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel
Conditions: Non-small Cell Lung Cancer
Location: Hot Springs, Arkansas
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Conditions: Chronic Myeloid Leukemia
Location: Hot Springs National Park, Arkansas
- Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM2)
Conditions: Bipolar Disorder, Pediatric
Location: Little Rock, Arkansas
- A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Conditions: Oral Mucositis
Location: Hot Springs, Arkansas
- Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Hot Springs, Arkansas
- Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Hot Springs, Arkansas
- A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Conditions: Psoriasis
Location: Hot Springs, Arkansas
- Smoking Cessation Study In Healthy Adolescent Smokers
Conditions: Smoking Cessation
Location: Hot Springs, Arkansas
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Hot Springs, Arkansas
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Little Rock, Arkansas
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Little Rock, Arkansas
- Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis
Conditions: Peripheral Arterial Disease
Location: Little Rock, Arkansas
- Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM2)
Conditions: Bipolar Disorder
Location: Little Rock, Arkansas
- Allopurinol Outcome Study
Conditions: Gout
Location: Little Rock, Arkansas
- Cariprazine Relative to Placebo in the Prevention of Relapse of Symptoms in Patients With Schizophrenia
Conditions: Schizophrenia
Location: Little Rock, Arkansas
- The OMEGA Clinical Trial
Conditions: Atherosclerosis - Coronary Artery Disease
Location: Little Rock, Arkansas
- A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Patients With HER2-Positive Breast Cancer Who Have Received at
Conditions: Breast Cancer
Location: Hot Springs, Arkansas
- Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
Conditions: Low Back Pain
Location: Hot Springs, Arkansas
- Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
Conditions: Low Back Pain
Location: Little Rock, Arkansas
- A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opi
Conditions: Low Back Pain
Location: Hot Springs, Arkansas
- The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Conditions: Chronic Idiopathic Constipation
Location: Little Rock, Arkansas
- PEARL Schizophrenia Maintenance
Conditions: Schizophrenia
Location: Little Rock, Arkansas
- A Study of RG1662 in Individuals With Down Syndrome
Conditions: Down Syndrome
Location: Little Rock, Arkansas
- Open Label Study of Long Term Evaluation Against LDL-C Trial (OSLER)
Conditions: Hypercholesterolemia
Location: Malvern, Arkansas
- A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Conditions: Thrombocytopaenia
Location: Hot Springs, Arkansas
- Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinu
Conditions: Small Cell Lung Carcinoma
Location: Hot Springs, Arkansas
- A Study to Evaluate the Efficacy and Safety of ALKS 9072 in Subjects With Schizophrenia
Conditions: Schizophrenia
Location: Little Rock, Arkansas
- An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)
Conditions: Critical Limb Ischemia
Location: Little Rock, Arkansas
- A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Conditions: Type 2 Diabetes Mellitus - Chronic Kidney Disease
Location: Little Rock, Arkansas
- A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Patients With Hormone Receptor-Positive, Metastatic HER2-positive
Conditions: Breast Cancer
Location: Hot Springs, Arkansas
- A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Conditions: Irritable Bowel Syndrome
Location: Little Rock, Arkansas
- Phase 3 Papulopustular Rosacea Study
Conditions: Papulopustular Rosacea
Location: Hot Springs, Arkansas
- Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Conditions: Diabetic Peripheral Neuropathy
Location: Hot Springs, Arkansas
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin
Conditions: Type 2 Diabetes Mellitus
Location: Hot Springs, Arkansas
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy
Conditions: Type 2 Diabetes Mellitus
Location: Hot Springs, Arkansas
- Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
Conditions: Tophaceous Gout
Location: Little Rock, Arkansas
- Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
Conditions: Attention-deficit/Hyperactivity Disorder
Location: Little Rock, Arkansas
- Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
Conditions: Attention-deficit/Hyperactivity Disorder
Location: Little Rock, Arkansas
- Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
Conditions: Restless Legs Syndrome
Location: Little Rock, Arkansas
- A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C
Conditions: Hepatitis C
Location: Little Rock, Arkansas
- A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)
Conditions: Psoriasis
Location: Little Rock, Arkansas
|